Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.09 CAD | +0.43% | +2.25% | +25.67% |
15/04 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
12/04 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.67% | 14.32B | |
+11.51% | 306B | |
+12.19% | 153B | |
+58.08% | 124B | |
+23.06% | 83.43B | |
+12.65% | 78.06B | |
+21.66% | 62.81B | |
+14.27% | 60.08B | |
+13.16% | 49.91B | |
+32.74% | 37.05B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Barclays Adjusts Price Target on Ovintiv to $60 From $69, Maintains Overweight Rating